Leicester - Latest News Update, Information, Photos & Videos on Leicester at Lokmat Times

International genomics research led by the University of Leicester has used artificial intelligence (AI) to study an aggressive form of cancer, which could improve patient outcomes.Mesothelioma is caused by breathing asbestos particles and most commonly occurs in the linings of the lungs or abdomen. Currently, only seven per cent of people survive five years after diagnosis, with a prognosis averaging 12 to 18 months.New research undertaken by the Leicester Mesothelioma Research Programme has now revealed, using AI analysis of DNA-sequenced mesotheliomas, that they evolve along similar or repeated paths between individuals. These paths predict the aggressiveness and possible therapy of this otherwise incurable cancer.Professor Dean Fennell, Chair of Thoracic Medical Oncology at the University of Leicester and Director of the Leicester Mesothelioma Research Programme, said:"It has long been appreciated that asbestos causes mesothelioma, however, how this occurs remains a mystery."Using AI to interrogate genomic 'big data', this initial work shows us that mesotheliomas follow ordered paths of mutations during development and that these so-called trajectories predict not only how long a patient may survive, but also how to better treat cancer - something Leicester aims to lead on internationally through clinical trial initiatives."While the use of asbestos is now outlawed - and stringent regulations in place on its removal - each year around 25 people are diagnosed with mesothelioma in Leicestershire and 190 are diagnosed in the East Midlands. Cases of mesothelioma in the UK have increased by 61 per cent since the early 1990s.Until very recently, chemotherapy was the only licenced choice for patients with mesothelioma. However, treatment options start to become limited once people stop responding to their treatment.Professor Fennell in collaboration with the University of Southampton recently made a major breakthrough in treating the disease by demonstrating that the use of an immunotherapy drug called nivolumab increased survival and stabilised the disease for patients. This was the first-ever trial to demonstrate improved survival in patients with relapsed mesothelioma.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

LeicesterFOLLOW

Leicester, Latest News

UK-based and award-winning radio presenter, Raj Baddhan will be making a comeback to a new weekday 'Drivetime' show on Lyca Radio. Baddhan joined Lyca Media in January 2021 and will be leading the business as its CEO. ...

Ahead of the match against Tottenham, Manchester United's Harry Maguire praised oppositions player Harry Kane, terming him "one of the best in the world" and said he is ready for the battle against his England teammate. ...

Manchester United midfielder Bruno Fernandes said that young striker Mason Greenwood, who scored the late winner at Old Trafford in the 2-1 win over Brighton, will keep on scoring more goals in the coming seasons. ...

Leicester City striker Kelechi Iheanacho has signed a new deal with the club, which will see him remain at King Power Stadium until at least 2024. ...

Ahead of the Leicester City clash in the Premier League, Manchester City boss Pep Guardiola is confident that defender John Stones will be able to rectify his mistakes when he will play at the King Power Stadium on Saturday. ...

Liverpool manager Jurgen Klopp on Friday confirmed that Roberto Firmino is in contention for the club's upcoming clash against Arsenal. ...

A new international genomics research led by the University of Leicester used artificial intelligence (AI) to study an aggressive form of cancer, which could be helpful in improving patient outcomes. ...

International genomics research led by the University of Leicester has used artificial intelligence (AI) to study an aggressive form of cancer, which could improve patient outcomes. ...